Vicken Karageozian, MD, discusses results of a phase-2 trial of an anti-integrin drug for diabetic macular edema.
To view the video, please visit EyeWorld Video Reporter: “Allegro at the Ophthalmology Innovation Summit @AAO 2017”
Vicken Karageozian, MD, discusses results of a phase-2 trial of an anti-integrin drug for diabetic macular edema.
To view the video, please visit EyeWorld Video Reporter: “Allegro at the Ophthalmology Innovation Summit @AAO 2017”